A Study to Investigate Safety and Preliminary Efficacy of SOA101 in Adult Subjects With Advanced Solid Tumors

NCT07055594 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: SOA101

Sponsor

Shine-On Biomedical Co., Ltd.